Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis.

Duan, Hanying; Zhu, Lijun; Li, Min; Zhang, Xinyue; Zhang, Beilin; Fang, Shaokuan

Duan, Hanying; Zhu, Lijun; Li, Min; Zhang, Xinyue; Zhang, Beilin; Fang, Shaokuan.

Afiliação

Duan H; Department of Neurology, Neuroscience Centre, The First Hospital of Jilin University, Changchun, China.
Zhu L; China-Japan Union Hospital of Jilin University, Changchun, China.
Li M; Department of Neurology, Neuroscience Centre, The First Hospital of Jilin University, Changchun, China.
Zhang X; Department of Neurology, Neuroscience Centre, The First Hospital of Jilin University, Changchun, China.
Zhang B; Department of Neurology, Neuroscience Centre, The First Hospital of Jilin University, Changchun, China.
Fang S; Department of Neurology, Neuroscience Centre, The First Hospital of Jilin University, Changchun, China.

Front Pharmacol ; 13: 949823, 2022.

Article em En | MEDLINE | ID: mdl-36147335

Palavras-chave

acceptability; antidepressants; binge eating disorder; efficacy; network meta-analysis; selective serotonin reuptake inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google